Claudin7 and moesin in endometrial Adenocarcinoma; A retrospective study of 265 patients

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Mhawech Fauceglia, Paulette ^a,c   Wang, Dan ^a   Lele, Shashikant ^a   Frederick, Peter J ^a   Pejovic, Tanja ^b   Liu, Song ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Claudin7; Clinical outcome; Endometrial adenocarcinoma; Moesin

Indexed keywords

EID: 84862777871     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-65     Document Type: Article

References (28)

1. Cancer statistics, 2009. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ, CA Cancer J Clin 2009 59 225 249 10.3322/caac.20006 19474385
2. Endometrial cancer state of the science meeting. Kitchener HC, Trimble EL, Int J Gynecol Cancer 2009 19 134 140 10.1111/IGC.0b013e3181995f90 19258955
3. Uterine papillary serous carcinoma: state of the state. Naumann RW, Curr Oncol Rep 2008 10 505 511 10.1007/s11912-008-0076-x 18928665
4. Pure papillary serous tumors of the endometrium: a clinicopathological analysis of 61 cases from a single institution. Benito V, Lubrano A, Arencibia O, Alvarez EE, Leán L, Medina N, Falcán JM, Falcán O, Int J Gynecol Cancer 2009 19 1364 1369 10.1111/IGC.0b013e3181b7a1d5 20009891
5. Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma. Mhawech-Fauceglia P, Wang D, Kesterson J, Clark K, Monhollen L, Odunsi K, Lele S, Liu S, PLoS One 2010 5 15415 21079744
6. Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid Adenocarcinoma. Mhawech-Fauceglia P, Wang D, Wang D, Syriac S, Kesterson J, Clark K, Frederick P, Lele S, Liu S, PLoS One 2011 6 18066 10.1371/journal.pone.0018066 21448288
7. A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites. Sato N, Funayama N, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S, J Cell Sci 1992 103 131 143 1429901
8. Emerging role of ERM proteins in cell adhesion and migration. Arpin M, Chirivino D, Naba A, Zwaenepoel I, Cell Adh Migr 2011 1 5 199 206
9. moesin/ezrin: a specific role in cell metastasis? Lallemand D, Arpin M, Pigment Cell Melanoma Res 2010 23 6 7 10.1111/j.1755-148X.2009.00650.x 19863757
10. ERM proteins: From cellular architecture to cell signaling. Louvet-Vallee S, Biology of the cell 2000 92 305 316 10.1016/S0248-4900(00)01078-9 11071040
11. Ezrin, a key component in tumor metastasis. Hunter KW, Trends Mol Med 2004 10 201 204 10.1016/j.molmed.2004.03.001 15121044 (Pubitemid 38581790)
12. Moesin-dependent cytoskeleton remodelling is associated with an anaplastic phenotype of pancreatic cancer. Abiatari I, Esposito I, Oliveira TD, Felix K, Xin H, Penzel R, Giese T, Friess H, Kleeff J, J Cell Mol Med 2010 14 1166 1179 19432821
13. ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. Ou-Yang M, Liu H-R, Zhang Y, Zhu X, Yang Q, Biochimie 2011 93 954 961 10.1016/j.biochi.2011.01.017 21352885
14. Claudins in human cancer: A review. Ouban A, Ahmed AA, Histol Histopathol 2010 25 83 90 19924644
15. Caludin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer. Konecny GE, Agarwal R, Keeney GA, Winterhoff B, mariani A, Riehle D, Neuper C, Dowdy SC, Wang HJ, Morin PJ, Podratz KC, Gynecol Oncol 2008 109 263 269 10.1016/j.ygyno.2008.01.024 18313739
16. Claudins as diagnostic and prognostic markers in gynecological cancer. Kiss A, Schaff Z, Sobel G, Histol Histopathol 2009 24 1607 1615 19795358
17. Hypermethylation-modulated downregulation of claudin-7 expression promotes the progression of colorectal carcinoma. Nakayama F, Semba S, Usami Y, Chiba H, Sawada N, Yokozaki H, Pathobiology 2008 75 177 185 10.1159/000124978 18550915
18. Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis. Szasz AM, Tokes AM, Micsinai M, Krenacs T, Jakab C, Lukacs L, Nemeth Z, Baranyai Z, Dede K, Madaras L, Kulka J, Clin Exp Metastasis 2011 28 55 63 10.1007/s10585-010-9357-5 20963473
19. Oral squamous cell carcinoma: status of tight junction claudins in the different histopathological patterns and relationship with clinical parameters. A tissue-microarray-based study of 136 cases. Lourenco SV, Coutinho-Camillo CM, Buim ME, Pereira CM, Carvalho AL, kowalski LP, Soares FA, J Clin Pathol 2010 63 609 614 10.1136/jcp.2009.070409 20591911
20. Revision in classification by International Federation of Gynecology and Obstetrics. Creasman WT, Am J Obstet Gynecol 1992 167 857 858 1326895
21. expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue. Pan XY, Wang B, Che YC, Weng ZP, Dai HY, Peng W, Int j Gynecol Cancer 2007 17 233 241 10.1111/j.1525-1438.2006.00748.x 17291259 (Pubitemid 46213996)
22. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using clostriduim perfringens enterotoxin (CPE). Santin AD, Bellone S, Marizzoni M, Palmieri M, Seigel ER, McKenney JK, Hennings L, Comper F, Bandiera E, Pecorelli S, Cancer 2007 109 1312 1322 10.1002/cncr.22536 17326053 (Pubitemid 46466558)
23. Gene expression fingerprint of uterine serous papillary carcinomas: identification of novel molecular markers of uterine serous cancer diagnosis and therapy. Santin AD, Zhan F, Cane' S, Bellone S, Palmieri M, Thomas M, Burnett A, Roman JJ, Cannon MJ, Shaughnessy J Jr, Pecorelli S, Br J Cancer 2005 92 1561 1573 10.1038/sj.bjc.6602480 15785748 (Pubitemid 40705026)
24. Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Ohtani K, Sakamoto H, Rutherford T, Chen Z, Kikucji A, Yamamoto T, Satoh K, Naftolin F, Cancer Lett 2002 179 79 86 10.1016/S0304-3835(01)00857-6 11880185 (Pubitemid 34195656)
25. Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Ohtani K, Sakamoto H, Rutherford T, Chen Z, Satoh K, Naftolin F, Cancer Lett 1999 147 31 38 10.1016/S0304-3835(99)00272-4 10660086
26. Ezrin expression is related to poor prognosis in FIGO I endometrioid carcinomas. Kobel M, Langhammer T, Huttelmaier S, Scmitt WD, Kriese K, Dittmer J, Strauss H-G, Thomssen C, Hauptmann S, Mod Pathol 2006 19 581 587 10.1038/modpathol.3800567 16554733
27. Altered expression of the ERM proteins in lung adenocarcinoma. Tokunou M, Niki T, Saitoh Y, Imamura H, Sakamoto M, Hirohashi S, Lab Invest 2000 80 1643 1650 10.1038/labinvest.3780174 11092524
28. Clincial significance of cellular distribution of moesin in patients with oral squamous cell carcinoma. Kobayashi H, Sagara J, Kurita H, Morifuji M, Ohishi M, Kurashina K, Taniguchi A, Clin Cancer Res 2004 10 572 580 10.1158/1078-0432.CCR-1323-03 14760079 (Pubitemid 38173996)